NAIAD Drug Design
Artificial Intelligence, Bioinformatics, Biotechnology, Pharmaceutical
Founded in 1/1/18
Santo André, Sao Paulo, Brazil
For Profit
About NAIAD Drug Design
NAIAD is an early-stage drug discovery startup focused on the development of new drugs targeting G-Protein coupled receptors GPCRs. NAIAD's platform integrates molecular modelling, bioinformatics, chemoinformatics and AI in order to perform in silico screnings with a throughput of billions of molecules. The company currently have four ongoing projects in its pipeline.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: None USD
- Last Funding: None (Seed)
- Funding Status: Seed
Technology Stack
NAIAD Drug Design actively uses None products in their tech stack.
Market Presence
Industries: Artificial Intelligence, Bioinformatics, Biotechnology, Pharmaceutical
Headquarters: Santo André, Sao Paulo, Brazil